09/08/2015 | Mark Hillen, Roisin McGuigan
AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.
09/07/2015 | Roisin McGuigan
Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.
08/11/2015 | Roisin McGuigan
“Smart” nanowires deliver drugs on demand using an applied electromagnetic field
Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?
An updated surgical technique restores sensation to patients with corneal anesthesia
The Argus II: Thirty Patients with RP, Three Years Later
06/09/2015 | Mark Hillen, Roisin McGuigan, Michael Schubert
Tumbling Es and Philanthropy
06/08/2015 | Roisin McGuigan
A protein involved in autophagy, DRAM2, appears to be essential for photoreceptor survival
A smartphone app could simplify strabismus screening and pave the way for telemedicine
06/08/2015 | Mark Hillen, Roisin McGuigan, Michael Schubert
See More. Treat More Effectively
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: